Recently the Food And Drug Administration authorized bremelanotide (Vyleesi), a brand new medicine for premenopausal ladies with hypoactive sexual interest disorder (HSDD). HSDD is a phrase coined to spell it out low sexual interest with no cause that is clear. Therefore, ladies who might choose to test this drug that is new to learn that it’s perhaps not meant to assist in circumstances where desire diminishes as a result of
- a medical or psychiatric disease
- social or relationship dilemmas
- negative effects from another therapy or medicine.